search again

Dronabinol, Oral

Nationwide rates for HCPCS Q0167

Dronabinol, 2.5 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $2 · 10th–90th $1$80%20%10th90th$2Professionalmedian $2 · 10th–90th $1$30%50%10th90th$2$0.1$2.0$50.0$1.0K$20.0K$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1.66
Median
$3.02
Typical High
$10.72
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1.66
Median
$1.66
Typical High
$2.00
BCBS
Setting
Facility
Modifier
Global
Typical Low
$1.62
Median
$2.04
Typical High
$4.57
BCBS
Setting
Professional
Modifier
Global
Typical Low
$1.66
Median
$1.66
Typical High
$2.34
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1.70
Median
$2.82
Typical High
$7.24
Cigna
Setting
Professional
Modifier
Global
Typical Low
$1.66
Median
$1.66
Typical High
$2.04
United
Setting
Facility
Modifier
Global
Typical Low
$1.35
Median
$2.00
Typical High
$3.55
United
Setting
Professional
Modifier
Global
Typical Low
$1.35
Median
$1.74
Typical High
$2.95